X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (37) 37
female (29) 29
index medicus (29) 29
male (26) 26
adult (24) 24
middle aged (21) 21
magnetic resonance imaging (18) 18
clinical neurology (17) 17
neurosciences (12) 12
aged (11) 11
neurology (11) 11
progressive multifocal leukoencephalopathy (11) 11
medicine & public health (10) 10
young adult (9) 9
adolescent (8) 8
leukoencephalopathy (8) 8
multiple-sclerosis (8) 8
neuroradiology (8) 8
central-nervous-system (7) 7
radiology, nuclear medicine & medical imaging (7) 7
surgery (7) 7
tomography, x-ray computed (7) 7
diagnosis (6) 6
magnetic resonance imaging - methods (6) 6
nuclear magnetic resonance--nmr (6) 6
retrospective studies (6) 6
cerebrospinal fluid (5) 5
hiv (5) 5
infectious diseases (5) 5
jc virus (5) 5
mri (5) 5
multiple sclerosis (5) 5
patients (5) 5
psychiatry (5) 5
risk (5) 5
viruses (5) 5
aged, 80 and over (4) 4
care and treatment (4) 4
case report (4) 4
drug therapy (4) 4
hiv infections - drug therapy (4) 4
human immunodeficiency virus--hiv (4) 4
infection (4) 4
inflammation (4) 4
italy (4) 4
medical research (4) 4
medicine, experimental (4) 4
natalizumab (4) 4
nervous system (4) 4
research (4) 4
survival (4) 4
treatment outcome (4) 4
virus diseases (4) 4
abridged index medicus (3) 3
antiretroviral therapy (3) 3
antiretroviral therapy, highly active (3) 3
antiviral agents (3) 3
article (3) 3
atrophy (3) 3
brain (3) 3
case-control studies (3) 3
cerebrospinal-fluid (3) 3
deoxyribonucleic acid--dna (3) 3
development and progression (3) 3
disease (3) 3
early diagnosis (3) 3
hiv infections - complications (3) 3
hiv-1 (3) 3
immune reconstitution (3) 3
immunologic factors - therapeutic use (3) 3
immunology (3) 3
leukoencephalopathy, progressive multifocal (3) 3
leukoencephalopathy, progressive multifocal - diagnostic imaging (3) 3
leukoencephalopathy, progressive multifocal - etiology (3) 3
lymphocytes (3) 3
multiple sclerosis - diagnostic imaging (3) 3
multiple sclerosis - drug therapy (3) 3
neurosurgery (3) 3
orthopedics (3) 3
patient (3) 3
phenotype (3) 3
reconstitution inflammatory syndrome (3) 3
reproducibility of results (3) 3
research article (3) 3
survival rate (3) 3
active antiretroviral therapy (2) 2
adipose triglyceride lipase (2) 2
age (2) 2
aids (2) 2
analysis (2) 2
anatomy (2) 2
angiolipoma - diagnostic imaging (2) 2
angiolipoma - surgery (2) 2
brachial plexus neuropathies - diagnosis (2) 2
brain - pathology (2) 2
central nervous system (2) 2
child (2) 2
child, preschool (2) 2
cns (2) 2
complications and side effects (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, p. e0168376
Background The monoclonal antibody natalizumab (NTZ) is a highly effective treatment for patients with multiple sclerosis (MS). However, this drug is... 
TREATED MS PATIENTS | PATTERN | RECONSTITUTION INFLAMMATORY SYNDROME | MRI | RECOMMENDATIONS | MULTIDISCIPLINARY SCIENCES | DISABILITY | RISK | PATIENT | PML-IRIS | Multiple Sclerosis - mortality | Humans | Middle Aged | Natalizumab - adverse effects | Male | Multiple Sclerosis - diagnostic imaging | Survival Rate | Leukoencephalopathy, Progressive Multifocal - mortality | Disease-Free Survival | Leukoencephalopathy, Progressive Multifocal - chemically induced | Magnetic Resonance Imaging | JC Virus | Natalizumab - administration & dosage | Adult | Female | Leukoencephalopathy, Progressive Multifocal - diagnostic imaging | Retrospective Studies | Leukoencephalopathy, Progressive Multifocal - physiopathology | Multiple Sclerosis - drug therapy | Development and progression | Care and treatment | Multiple sclerosis | Drug therapy | Leukoencephalopathy, Progressive multifocal | Prevalence studies (Epidemiology) | Pictures | Neuroimaging | Brain | Nuclear magnetic resonance--NMR | Change detection | Central nervous system | Cognitive ability | Opportunist infection | Gadolinium | Cerebrospinal fluid | Leukoencephalopathy | Progressive multifocal leukoencephalopathy | Demographics | Restoration | Human immunodeficiency virus--HIV | Diagnosis | Age | Deoxyribonucleic acid--DNA | Immune system | Survival | Patients | Neurology | Magnetic resonance imaging | Monoclonal antibodies | Data collection | Psychiatry | Sociodemographics | Deoxyribonucleic acid | Nuclear magnetic resonance | NMR | HIV | DNA | Human immunodeficiency virus
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 7/2019, Volume 25, Issue 8, pp. 1196 - 1201
Journal Article
European Radiology, ISSN 0938-7994, 3/2016, Volume 26, Issue 3, pp. 693 - 705
Journal Article
AIDS, ISSN 0269-9370, 12/2019, Volume 33 Suppl 2, pp. S159 - S169
Cerebrospinal fluid (CSF) viral escape is defined by detectable HIV-RNA in CSF despite undetectable or lower-than-CSF level in plasma of patients receiving... 
Journal Article
Journal Article
Neurology, ISSN 0028-3878, 01/2018, Volume 90, Issue 2, pp. 83 - 85
Journal Article
Multiple Sclerosis Journal, ISSN 1352-4585, 05/2019, p. 135245851985416
Journal Article
Neurological Sciences, ISSN 1590-1874, 10/2019, Volume 40, Issue 10, pp. 2119 - 2124
Progressive multifocal leukoencephalopathy (PML) is a severe adverse event of natalizumab (NTZ). The administration of NTZ with extended interval dosing (EID)... 
Neurology | Multiple sclerosis | Early diagnosis | Medicine & Public Health | Natalizumab | Neurosurgery | Extended doses regimen | Psychiatry | Neuroradiology | Progressive multifocal leukoencephalopathy | MULTIPLE-SCLEROSIS | RISK | NEUROSCIENCES | CLINICAL NEUROLOGY | Magnetic resonance imaging | Risk groups | Aphasia | Immune reconstitution | Speech | Leukoencephalopathy
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 04/2018, Volume 89, Issue 4, pp. 441 - 444
Rituximab, in fact, has a high molecular weight and only 0.1%-0.5% of its plasmatic concentrations crosses the 'blood-brain barrier' (BBB) after intravenous... 
Edema | Optic nerve | Lymphocytes | Nervous system | Inflammation | Lymphomas | Patients
Journal Article
Journal of Neurology, ISSN 0340-5354, 2/2018, Volume 265, Issue 2, pp. 273 - 284
Journal Article